Rockwell Medical Analyst Ratings
Rockwell Medical Analyst Ratings
While ratings are subjective and will change, the latest Rockwell Medical (RMTI) rating was a reiterated with a price target of $0.00 to $11.00. The current price Rockwell Medical (RMTI) is trading at is $2.11, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | 421.33% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 10/05/2023 | 136.97% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 10/04/2023 | 421.33% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 09/28/2023 | 421.33% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 08/15/2023 | 421.33% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 07/17/2023 | 421.33% | HC Wainwright & Co. | $9 → $11 | Maintains | Buy |
| 05/30/2023 | 326.54% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 05/02/2023 | 231.75% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 04/04/2023 | 231.75% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/13/2023 | 231.75% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/08/2023 | 231.75% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 08/30/2022 | 279.15% | HC Wainwright & Co. | $3 → $8 | Maintains | Buy |
| 01/18/2022 | 42.18% | HC Wainwright & Co. | $5 → $3 | Maintains | Buy |
| 09/07/2021 | 136.97% | HC Wainwright & Co. | $5.5 → $5 | Maintains | Buy |
| 02/08/2021 | 160.66% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 04/07/2020 | 326.54% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
| 11/12/2019 | 184.36% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 06/25/2019 | 421.33% | Cantor Fitzgerald | → $11 | Initiates Coverage On | → Overweight |
| 06/24/2019 | 373.93% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/15/2023 | 421.33% | HC Wainwright & Co. | → 11 美元 | 重申 | 购买 → 购买 |
| 10/05/2023 | 136.97% | Maxim 集团 | → 5 美元 | 启动覆盖范围开启 | → 购买 |
| 2023 年 4 月 10 日 | 421.33% | HC Wainwright & Co. | → 11 美元 | 重申 | 购买 → 购买 |
| 09/28/2023 | 421.33% | HC Wainwright & Co. | → 11 美元 | 重申 | 购买 → 购买 |
| 08/15/2023 | 421.33% | HC Wainwright & Co. | → 11 美元 | 重申 | 购买 → 购买 |
| 07/17/2023 | 421.33% | HC Wainwright & Co. | 9 美元 → 11 美元 | 维护 | 买 |
| 05/30/2023 | 326.54% | HC Wainwright & Co. | 7 美元 → 9 美元 | 维护 | 买 |
| 05/02/2023 | 231.75% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 04/04/2023 | 231.75% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 02/13/2023 | 231.75% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 02/08/2023 | 231.75% | HC Wainwright & Co. | 8 美元 → 7 美元 | 维护 | 买 |
| 08/30/2022 | 279.15% | HC Wainwright & Co. | 3 美元 → 8 美元 | 维护 | 买 |
| 01/18/2022 | 42.18% | HC Wainwright & Co. | 5 美元 → 3 美元 | 维护 | 买 |
| 09/07/2021 | 136.97% | HC Wainwright & Co. | 5.5 美元 → 5 美元 | 维护 | 买 |
| 02/08/2021 | 160.66% | HC Wainwright & Co. | 9 美元 → 5.5 美元 | 维护 | 买 |
| 04/07/2020 | 326.54% | HC Wainwright & Co. | 11 美元 → 9 美元 | 维护 | 买 |
| 2019 年 12 月 11 日 | 184.36% | 派珀·桑德勒 | 10 美元 → 6 美元 | 维护 | 超重 |
| 06/25/2019 | 421.33% | 坎托·菲茨杰拉德 | → 11 美元 | 启动覆盖范围开启 | → 超重 |
| 06/24/2019 | 373.93% | 派珀·桑德勒 | → 10 美元 | 启动覆盖范围开启 | → 超重 |
What is the target price for Rockwell Medical (RMTI)?
罗克韦尔医疗（RMTI）的目标价格是多少？
The latest price target for Rockwell Medical (NASDAQ: RMTI) was reported by HC Wainwright & Co. on November 15, 2023. The analyst firm set a price target for $11.00 expecting RMTI to rise to within 12 months (a possible 421.33% upside). 11 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年11月15日公布了罗克韦尔医疗（纳斯达克股票代码：RMTI）的最新目标股价。该分析公司将目标股价定为11.00美元，预计RMTI将在12个月内升至12个月内（可能上涨421.33％）。去年有11家分析公司公布了评级。
What is the most recent analyst rating for Rockwell Medical (RMTI)?
罗克韦尔医疗（RMTI）的最新分析师评级是多少？
The latest analyst rating for Rockwell Medical (NASDAQ: RMTI) was provided by HC Wainwright & Co., and Rockwell Medical reiterated their buy rating.
Rockwell Medical（纳斯达克股票代码：RMTI）的最新分析师评级由HC Wainwright & Co. 提供，罗克韦尔医疗重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Rockwell Medical (RMTI)?
罗克韦尔医疗（RMTI）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rockwell Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rockwell Medical was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与罗克韦尔医疗公司的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。罗克韦尔医疗的最新评级是在2023年11月15日公布的，因此您应该预计下一个评级将在2024年11月15日左右公布。
Is the Analyst Rating Rockwell Medical (RMTI) correct?
分析师对罗克韦尔医疗（RMTI）的评级是否正确？
While ratings are subjective and will change, the latest Rockwell Medical (RMTI) rating was a reiterated with a price target of $0.00 to $11.00. The current price Rockwell Medical (RMTI) is trading at is $2.11, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的罗克韦尔医疗（RMTI）评级，目标股价为0.00美元至11.00美元。罗克韦尔医疗（RMTI）目前的交易价格为2.11美元，在分析师的预测区间内。
